Author:
Sato-Kawano Nanae,Takemoto Minoru,Okabe Emiko,Yokote Koutaro,Matsuo Muneaki,Kosaki Rika,Ihara Kenji
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference19 articles.
1. Gordon, L. B., Brown, W. T., Collins, F. S. in GeneReviews(R)(eds Pagon, R. A., Adam, M. P., Ardinger, H. H., Wallace, S. E., Amemiya, A., Bean, L. J. H. et al (1993). https://www.ncbi.nlm.nih.gov/pubmed/20301300.
2. Hennekam, R. C. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. A 140, 2603–2624 (2006).
3. Merideth, M. A., Gordon, L. B., Clauss, S., Sachdev, V., Smith, A. C., Perry, M. B. et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N. Engl. J. Med. 358, 592–604 (2008).
4. Mazereeuw-Hautier, J., Wilson, L. C., Mohammed, S., Smallwood, D., Shackleton, S., Atherton, D. J. et al. Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature. Br. J. Dermatol. 156, 1308–1314 (2007).
5. Gordon, L. B., Kleinman, M. E., Massaro, J., D'Agostino, R. B. Sr, Shappell, H., Gerhard-Herman, M. et al. Clinical trial of the protein farnesylation inhibitors lonafarnib, pravastatin, and zoledronic acid in children with Hutchinson-Gilford progeria syndrome. Circulation 134, 114–125 (2016).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献